184 filings
Page 7 of 10
6-K
EVAX
Evaxion Biotech A/S
15 Mar 22
Evaxion Biotech Strengthens Management Team with Two Senior Appointments
9:26am
6-K
EVAX
Evaxion Biotech A/S
7 Mar 22
Evaxion Biotech Completes Recruitment for Phase 1/2a Clinical Trial for EVX-02
4:17pm
6-K
EVAX
Evaxion Biotech A/S
11 Feb 22
Current report (foreign)
5:00pm
6-K
EVAX
Evaxion Biotech A/S
18 Jan 22
Evaxion Biotech Receives Regulatory Clearance to Initiate Phase 2 Trial of EVX-01 in Combination with KEYTRUDA® for Treatment of Melanoma
4:30pm
6-K
EVAX
Evaxion Biotech A/S
10 Nov 21
Current report (foreign)
4:40pm
6-K
EVAX
Evaxion Biotech A/S
9 Nov 21
Current report (foreign)
5:00pm
6-K
EVAX
Evaxion Biotech A/S
9 Nov 21
Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update
6:29am
424B4
EVAX
Evaxion Biotech A/S
5 Nov 21
Prospectus supplement with pricing info
4:47pm
6-K
EVAX
Evaxion Biotech A/S
5 Nov 21
Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering
8:30am
EFFECT
EVAX
Evaxion Biotech A/S
5 Nov 21
Notice of effectiveness
12:15am
F-1MEF
EVAX
Evaxion Biotech A/S
4 Nov 21
Registration statement to add securities to prior F-1 registration
8:19pm
F-1/A
EVAX
Evaxion Biotech A/S
3 Nov 21
Registration statement (foreign) (amended)
7:50am
CORRESP
EVAX
Evaxion Biotech A/S
3 Nov 21
Correspondence with SEC
12:00am
CORRESP
EVAX
Evaxion Biotech A/S
3 Nov 21
Correspondence with SEC
12:00am
CORRESP
EVAX
Evaxion Biotech A/S
29 Oct 21
Correspondence with SEC
12:00am
CORRESP
EVAX
Evaxion Biotech A/S
29 Oct 21
Correspondence with SEC
12:00am
6-K
EVAX
Evaxion Biotech A/S
27 Oct 21
Evaxion Biotech Announces Filing of Registration Statement in the U.S for Proposed Follow-on Public Offering to Raise Additional Capital
4:29pm
6-K
EVAX
Evaxion Biotech A/S
26 Oct 21
Current report (foreign)
8:14am
F-1
EVAX
Evaxion Biotech A/S
26 Oct 21
Registration statement (foreign)
7:02am
6-K
EVAX
Evaxion Biotech A/S
25 Oct 21
Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma
6:00am